Quick Takeaways
- Datuk Dr. Doris Wong Sing Ee filed SCHEDULE 13D for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CYCC).
- Disclosed ownership: 70%.
- Date of event: 26 Feb 2025.
Datuk Dr. Doris Wong Sing Ee - 26 Feb 2025 SCHEDULE 13D Report for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CYCC)
- Filing Manager
- Datuk Dr. Doris Wong Sing Ee
- Reporting Manager
- Doris Wong Sing Ee
- Symbol
- CYCC
- Shares outstanding
- 278,041,171 shares
- Disclosed Ownership
- 194,628,820 shares
- Ownership
- 70%
- Form type
- SCHEDULE 13D
- Filing time
- 04 Mar 2025, 10:32:06 UTC
- Date of event
- 26 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Datuk Dr. Doris Wong Sing Ee disclosed 70% ownership in Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (CYCC) on 26 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Mar 2025, 10:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Doris Wong Sing Ee | 70% | 194,628,820 | 194,628,820 | 0 | /s/ Datuk Dr. Doris Wong Sing Ee | Chief Executive Officer | 0001892421 |